Cargando…
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data
BACKGROUND: The objective of the study is to estimate the frequency of multimorbidity in type 2 diabetes patients classified by health statuses in a European region and to determine the impact on pharmaceutical expenditure. METHODS: Cross-sectional study of the inhabitants of a southeastern European...
Autores principales: | Sancho-Mestre, Carla, Vivas-Consuelo, David, Alvis-Estrada, Luis, Romero, Martin, Usó-Talamantes, Ruth, Caballer-Tarazona, Vicent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989292/ https://www.ncbi.nlm.nih.gov/pubmed/27534391 http://dx.doi.org/10.1186/s12913-016-1649-2 |
Ejemplares similares
-
Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool
por: Vivas-Consuelo, David, et al.
Publicado: (2014) -
Erratum to: Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool
por: Vivas-Consuelo, David, et al.
Publicado: (2017) -
Measurement of health-related quality by multimorbidity groups in primary health care
por: Millá-Perseguer, Magdalena, et al.
Publicado: (2019) -
A cost and performance comparison of Public Private Partnership and public hospitals in Spain
por: Caballer-Tarazona, Maria, et al.
Publicado: (2016) -
Erratum to: ‘A cost and performance comparison of Public Private Partnership and public hospitals in Spain’
por: Caballer-Tarazona, Maria, et al.
Publicado: (2016)